Mike Chirenje
Overview
Explore the profile of Mike Chirenje including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Velloza J, Hosek S, Donnell D, Anderson P, Chirenje M, Mgodi N, et al.
J Int AIDS Soc
. 2021 Jun;
24 Suppl 2:e25731.
PMID: 34164929
Introduction: African adolescent girls and young women (AGYW) eligible for HIV pre-exposure prophylaxis (PrEP) experience high levels of depressive symptoms. Depression can reduce PrEP adherence among adults, although analyses have...
2.
Nkhoma K, Ebenso B, Akeju D, Adejoh S, Bennett M, Chirenje M, et al.
BMC Palliat Care
. 2021 Jan;
20(1):4.
PMID: 33397321
Introduction: Coverage of palliative care in low and middle-income countries is very limited, and global projections suggest large increases in need. Novel approaches are needed to achieve the palliative care...
3.
Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, et al.
J Int AIDS Soc
. 2020 Mar;
23(3):e25463.
PMID: 32144874
Introduction: Stigma and disclosure concerns have been key barriers to oral pre-exposure prophylaxis (PrEP) adherence for African adolescent girls and young women (AGYW) in efficacy trials. We aimed to understand...
4.
Shacklett B, Blanco J, Hightow-Weidman L, Mgodi N, Alcami J, Buchbinder S, et al.
AIDS Res Hum Retroviruses
. 2019 Apr;
35(7):598-607.
PMID: 31007035
The HIV Research for Prevention (HIVR4P) conference is dedicated to advancing HIV prevention research, responding to a growing consensus that effective and durable prevention will require a combination of approaches...
5.
Ladner J, Besson M, Hampshire R, Tapert L, Chirenje M, Saba J
BMC Public Health
. 2012 May;
12:370.
PMID: 22621342
Background: Cervix cancer, preventable, continues to be the third most common cancer in women worldwide, especially in lowest income countries. Prophylactic HPV vaccination should help to reduce the morbidity and...
6.
Duri K, Gumbo F, Kristiansen K, Mapingure M, Munjoma M, Chirenje M, et al.
AIDS Res Hum Retroviruses
. 2011 Dec;
28(8):885-93.
PMID: 22206228
To characterize phylogenetic relatedness of plasma HIV-1 RNA subtype C env gp120 viral variants capable of establishing an infection following heterosexual and subsequent vertical transmission events a 650-base pair fragment...
7.
Woodsong C, Alleman P, Musara P, Chandipwisa A, Chirenje M, Martinson F, et al.
AIDS Behav
. 2011 Aug;
16(3):785-90.
PMID: 21863339
This paper presents empirical data on motivation to join an HIV prevention trial of vaginal microbicide gels in Malawi and Zimbabwe, and participant assumption of a preventive misconception. Interviews were...
8.
Smee N, Shetty A, Stranix-Chibanda L, Chirenje M, Chipato T, Maldonado Y, et al.
Womens Health Issues
. 2011 Mar;
21(3):222-9.
PMID: 21411336
Background: This study examined predictors of repeat pregnancy among women from the Prevention of Mother-to-Child Transmission of HIV (PMTCT) program in Zimbabwe. Methods: The study was conducted at urban antenatal...
9.
Sitas F, Parkin D, Chirenje M, Stein L, Abratt R, Wabinga H
Lancet Oncol
. 2008 Aug;
9(8):786-95.
PMID: 18672214
Africa has contributed substantial knowledge to the understanding of certain risk factors for cancer, such as the role of several infectious agents (eg, viruses, bacteria, and parasites), aflatoxins, and certain...
10.
Parkin D, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H
Lancet Oncol
. 2008 Jul;
9(7):683-92.
PMID: 18598933
Cancer is an under-emphasised issue in Africa, partly because of the overwhelming burden of communicable diseases. However cancer is a common disease in Africa with 650 000 people, of a...